Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as €65.30 ($70.98) and last traded at €63.70 ($69.24), with a volume of 194665 shares. The stock had previously closed at €65.50 ($71.20).
Carl Zeiss Meditec Price Performance
The company’s 50-day moving average is €81.89 and its two-hundred day moving average is €98.20. The company has a debt-to-equity ratio of 6.74, a current ratio of 3.51 and a quick ratio of 2.47. The firm has a market cap of $5.75 billion, a P/E ratio of 21.95, a PEG ratio of 3.45 and a beta of 0.93.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Sales Breakout Sends This Semiconductor Stock to Record High
- Earnings Per Share Calculator: How to Calculate EPS
- Surprise Buying Opportunity on This Dividend Aristocrat
- The 3 Best Blue-Chip Stocks to Buy Now
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
